Zydus Lifesciences Limited — Important, 03-06-2025: General Updates

Zydus Lifesciences has announced a board meeting to discuss the financial results for the quarter and half-year. The company is acquiring two biologics manufacturing facilities in California from Agenus Inc. for $75 million upfront plus up to $50 million on revenue milestones. This marks Zydus’ entry into the global biologics CDMO sector and secures exclusive manufacturing rights for certain Phase-3 immuno-oncology products, strengthening its presence in the fast-growing biologics market.